Dr Reddys Laboratories (RDY) Other Non Operating Income (2009 - 2018)
Dr Reddys Laboratories (RDY) posted quarterly Other Non Operating Income of -$9.0 million for Q2 2018, down 125.0% on a QoQ basis from -$4.0 million in Q1 2018.
Dr Reddys Laboratories (RDY) Other Non Operating Income (2009 - 2018) Analysis & Trends
Dr Reddys Laboratories (RDY) has reported Other Non Operating Income for 4 consecutive years, with -$9.0 million the latest figure, recorded in Q2 2018.
- Quarterly Other Non Operating Income changed N/A year-over-year to -$9.0 million in Q2 2018, while the trailing twelve-month figure through Jun 2018 was -$24.0 million (changed N/A YoY) and the FY2018 annual result came in at -$4.0 million, changed N/A from the prior year.
- Other Non Operating Income eased to -$9.0 million in Q2 2018 per RDY's latest filing, from -$4.0 million in the prior quarter.
- Over the last five years, Other Non Operating Income for RDY reached as high as -$4.0 million in Q1 2018 and fell as low as -$9.0 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Dr Reddys Laboratories | 9.82 Bn | 9.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -9.00 Mn |
| Mar 31, 2018 | -4.00 Mn |
| Sep 30, 2014 | -5.00 Mn |
| Mar 31, 2014 | -6.00 Mn |
| Mar 31, 2010 | -562.00 Mn |
| Dec 31, 2009 | -4.00 Mn |
| Sep 30, 2009 | -2.00 Mn |
| Jun 30, 2009 | -1.00 Mn |
| Mar 31, 2009 | 245.00 Mn |